LH 234.38 (+2.3%)
US50540R4092Medical Diagnostics & ResearchDiagnostics & Research

Laboratory Corp of America Holdings (LH) Competitor Comparison

We are evaluating the key criteria listed to compare Laboratory Corp of America Holdings (LH) against its competitors in the Diagnostics & Research industry.

Linearity 5 years - LH ranking 33 / 58

These are the competitors of Laboratory Corp of America Holdings in the industry Diagnostics & Research ranked by linearity 5 years
1. Co-Diagnostics CODX
42.73
2. Ortho Clinical Diagnostics Holdings OCDX
33.4
3. DarioHealth DRIO
31.71
4. Myriad Genetics MYGN
29.5
5. CareDx CDNA
28.79
6. Syneos Health SYNH
24.79
7. Anixa Biosciences ANIX
19.23
8. Heska HSKA
15.42
9. Exact Sciences EXAS
15.35
10. Pacific Biosciences of California PACB
9.77
11. Fulgent Genetics FLGT
8.66
12. Olink Holding OLK
8.53
13. Charles River Laboratories CRL
8.45
14. DexCom DXCM
8.4
15. Inotiv NOTV
8.38
16. Qiagen QGEN
7.58
17. NeoGenomics NEO
6.97
18. Trinity Biotech TRIB
6.41
19. Aspira Womens Health AWH
5.9
20. IDEXX Laboratories IDXX
5.43
21. Personalis PSNL
5.12
22. IQVIA Holdings IQV
5.09
23. Icon ICLR
5.01
24. Twist Bioscience TWST
4.99
25. PerkinElmer PKI
4.97
26. Illumina ILMN
4.66
27. Sotera Health SHC
4.29
28. Waters WAT
4.28
29. Guardant Health GH
4.17
30. Neogen NEOG
4.1
31. Bioventus BVS
3.99
32. Quest Diagnostics DGX
3.98
33. Laboratory Corp of America Holdings LH
3.71
34. Agilent Technologies A
3.63
35. Sera Prognostics SERA
3.48
36. Mettler-Toledo MTD
3.31
37. Enzo Biochem ENZ
3.27
38. National Research NRC
3.09
39. Thermo Fisher Scientific TMO
3.02
40. Psychemedics PMD
2.56
41. Interpace Biosciences IDXG
2.54
42. Danaher DHR
2.5
43. Precipio PRPO
2.3
44. Neuronetics STIM
2.28
45. Global Cord Blood CO
2.23
46. MaxCyte MXCT
2.05
47. MDxHealth MDXH
2.03
48. Exagen XGN
2.01
49. Biodesix BDSX
1.96
50. Prenetics Global PRE
1.81
51. Organovo Holdings ONVO
1.6
52. bioAffinity Technologies BIAF
1.6
53. SeqLL SQL
1.38
54. Meridian Bioscience VIVO
0.99
55. Natera NTRA
0.81
56. Medpace Holdings MEDP
0.67
57. RadNet RDNT
0.39
58. Lantheus Holdings LNTH
0.25

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.